Light Mode
$0.0521 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0521, and at the day’s high of $0.0524
-0.05 (-50.19%) / 6M
Momentum, market sentiment, and recent alerts
IMUC reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -71.0%.
No alerts for IMUC in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.